A probable case of West Nile virus transfusion transmission

Transfusion

Volumn 57, Issue 3, 2017, Pages 850-856

  Groves, Jamel A ^a   Shafi, Hedyeh ^b   Nomura, Jim H ^c   Herron, Ross M ^a   Baez, Devin ^a   Dodd, Roger Y ^a   Stramer, Susan L ^a  

^a AMERICAN RED CROSS   (United States)

^b KAISER PERMANENTE   (United States)

^c LOS ANGELES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; FRESH FROZEN PLASMA; HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PIPERACILLIN PLUS TAZOBACTAM; VIRUS ANTIBODY;

AGED; ANTIBIOTIC THERAPY; AORTA VALVE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTERY CALCIFICATION; ARTICLE; ARTIFICIAL VENTILATION; ASEPTIC MENINGITIS; BLOOD COMPONENT; BLOOD DONOR; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CONFUSION; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CRYOPRECIPITATE; DYSPNEA; ECHOCARDIOGRAPHY; ENCEPHALITIS; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; FEVER; HEART CATHETERIZATION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUMBAR PUNCTURE; MALE; MEDICAL HISTORY; MOSQUITO BITE; MYALGIA; NEUTROPHIL COUNT; PERICARDIAL EFFUSION; SEROCONVERSION; TACHYCARDIA; TACHYPNEA; TRACHEOSTOMY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VIRUS TRANSMISSION; WEAKNESS; WEST NILE FEVER; WEST NILE VIRUS; AORTIC VALVE; BLOOD; BLOOD TRANSFUSION; CEREBROSPINAL FLUID; CORONARY ARTERY BYPASS GRAFT; HEART DISEASES; HEART VALVE REPLACEMENT; TRANSMISSION;

AGED; ANTIBODIES, VIRAL; AORTIC VALVE; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; HEART DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 85012933987     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14018     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention (CDC). ArboNET. West Nile virus disease cases and deaths reported to CDC by year and clinical presentation 1999-2015 [cited 2016 Nov 7]. Available from: http://www.cdc.gov/westnile/resources/pdfs/data/1-wnv-disease-cases-by-year_1999-2015_07072016.pdf.
2. Lindsey NP, Lehman JA, Staples JE, Fischer M. West Nile virus and other nationally notifiable arboviral diseases—United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:929-34.
3. Hadler JL, Patel D, Nasci RS, et al. Assessment of arbovirus surveillance 13 years after introduction of West Nile virus, United States. Emerg Infect Dis 2015;21:1159-66.
4. Ostroff SM. West Nile virus: too important to forget. JAMA 2013;310:267-8.
5. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
6. Dodd RY, Foster GA, Stramer SL. Keeping blood transfusion safe from West Nile virus: American Red Cross experience, 2003 to 2012. Transfus Med Rev 2015;29:153-61.
7. US Food and Drug Administration. Guidance for industry. Use of nucleic acid tests to reduce the risk of transmission of West Nile virus from donors of whole blood and blood components intended for transfusion. 2009 [cited 2016 Nov 11]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM189464.pdf.
8. Stramer SL, Markowitz MA. Association Bulletin 13-02: West Nile virus nucleic acid testing: revised recommendations. 2013 [cited 2016 Nov 22]. Available from: www.aabb.org.
9. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008;198:984-93.
10. Centers for Disease Control and Prevention (CDC). Update: West Nile virus screening of blood donations and transfusion-associated transmission—United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:281-4.
11. Centers for Disease Control and Prevention (CDC). West Nile virus transmission through blood transfusion—South Dakota, 2006. MMWR Morb Mortal Wkly Rep 2007;56:76-9.
12. Centers for Disease Control and Prevention (CDC). Fatal West Nile virus infection after probable transfusion-associated transmission— Colorado 2012. MMWR Morb Mortal Wkly Rep 2013;62:622-4.
13. Macedo de Oliveira A, Beecham BD, Montgomery SP, et al. West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion 2004;44:1695-9.
14. Montgomery SP, Brown JA, Kuehnert M, et al. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. Transfusion 2006;46:2038-46.
15. Meny GM, Santos-Zabala L, Szallasi A, Stramer SL. West Nile virus infection transmitted by granulocyte transfusion. Blood 2011;117:5778-9.
16. California Department of Public Health, Vector-Borne Disease Section (Infectious Diseases Branch): California Arbovirus Surveillance Bulletin 17. 2016 [cited 2016 Nov 2]. Available from: http://www.westnile.ca.gov/reports.php?report_category_id=6.
17. Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis 2010;202:1354-61.
18. Dodd RY. Emerging infections, transfusion safety, and epidemiology. New Engl J Med 2003;349:1205-6.
19. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005;353:451-45.
20. Biggerstaff BJ, Petersen LR. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus. Transfusion 2009;449:1151-9.